Tempus AI, Inc. (TEM) PB Ratio: 21.31
Is Tempus AI, Inc.’s P/B ratio high or low?
Tempus AI, Inc.'s P/B ratio of 21.31 is 69% below its 2-year average of 69.48, near the low end of its 2-year range (15.03–275.69).
26.42% below its 12-month average of 28.96.
TEM PB Ratio Chart
TEM Average PB Ratio Chart
TEM Current vs Average PB Ratio Chart
TEM PB Ratio Metrics
PB RATIO
21.31
PB RATIO AVG TTM
28.96
PB RATIO AVG 3Y
69.48
PB RATIO AVG 5Y
69.48
PB RATIO AVG 10Y
69.48
PB RATIO AVG 15Y
69.48
PB RATIO AVG 20Y
69.48
CURRENT VS TTM AVG
-26.42%
CURRENT VS 3Y AVG
-69.33%
CURRENT VS 5Y AVG
-69.33%
CURRENT VS 10Y AVG
-69.33%
CURRENT VS 15Y AVG
-69.33%
CURRENT VS 20Y AVG
-69.33%
TEM Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $8.65B | 21.31 | 28.96 | 69.48 | 69.48 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 3.13 | 2.63 | 2.83 | 4.02 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 1.15 | 1.11 | 1.14 | 1.29 |
| Baxter International Inc. (BAX) | $10.58B | 1.75 | 1.60 | 2.25 | 3.04 |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 14.23 | 16.87 | 13.09 | 9.59 |
| Align Technology, Inc. (ALGN) | $12.64B | 3.05 | 2.97 | 4.41 | 6.31 |
| Solventum Corporation (SOLV) | $13.72B | 2.80 | 3.05 | 3.38 | 3.38 |
| Hologic, Inc. (HOLX) | $16.97B | 3.27 | 3.17 | 3.48 | 3.78 |
| 23andMe Holding Co. (ME) | $15.31M | 0.51 | 0.50 | 0.88 | 1.62 |
| Moderna, Inc. (MRNA) | $19.70B | 2.65 | 1.61 | 2.06 | 4.93 |
P/B vs. its own history
At 21.31, P/B is cheaper than usual, sitting higher than 19% of its 2-year history.
2-year low
15.03
median
43.53
2-year high
275.69
Book Value Analysis
P/B Ratio
21.31
Market Price / Book Value per Share
Tempus AI, Inc. PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tempus AI, Inc. PB Ratio FAQ
- What is the P/B ratio for Tempus AI, Inc. (TEM)?
- The P/B ratio for TEM stock is 21.31.
- Is Tempus AI, Inc.'s P/B ratio high or low?
- Tempus AI, Inc.'s P/B ratio of 21.31 is 69% below its 2-year average of 69.48, near the low end of its 2-year range (15.03–275.69).
- What is the TTM average P/B ratio for Tempus AI, Inc. (TEM)?
- The TTM average P/B ratio for TEM stock is 28.96.
- What is the 3Y average P/B ratio for Tempus AI, Inc. (TEM)?
- The 3Y average P/B ratio for TEM stock is 69.48.
- What is the 5Y average P/B ratio for Tempus AI, Inc. (TEM)?
- The 5Y average P/B ratio for TEM stock is 69.48.
- What is the 10Y average P/B ratio for Tempus AI, Inc. (TEM)?
- The 10Y average P/B ratio for TEM stock is 69.48.
- What is the 15Y average P/B ratio for Tempus AI, Inc. (TEM)?
- The 15Y average P/B ratio for TEM stock is 69.48.
- What is the 20Y average P/B ratio for Tempus AI, Inc. (TEM)?
- The 20Y average P/B ratio for TEM stock is 69.48.
Tempus AI, Inc. PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-11 | 21.31 |
| 2026-06-10 | 21.27 |
| 2026-06-09 | 20.98 |
| 2026-06-08 | 20.88 |
| 2026-06-05 | 19.95 |
| 2026-06-04 | 22.46 |
| 2026-06-03 | 20.42 |
| 2026-06-02 | 21.33 |
| 2026-06-01 | 22.69 |
| 2026-05-29 | 21.69 |
| 2026-05-28 | 22.04 |
| 2026-05-27 | 20.27 |
| 2026-05-26 | 20.05 |
| 2026-05-22 | 19.85 |
| 2026-05-21 | 19.98 |
| 2026-05-20 | 19.72 |
| 2026-05-19 | 19.57 |
| 2026-05-18 | 18.75 |
| 2026-05-15 | 18.88 |
| 2026-05-14 | 19.55 |
| 2026-05-13 | 19.73 |
| 2026-05-12 | 20.18 |
| 2026-05-11 | 20.83 |
| 2026-05-08 | 21.43 |
| 2026-05-07 | 21.26 |
| 2026-05-06 | 22.99 |
| 2026-05-05 | 23.24 |
| 2026-05-04 | 19.79 |
| 2026-05-01 | 19.51 |
| 2026-04-30 | 19.68 |
| 2026-04-29 | 17.74 |
| 2026-04-28 | 18.12 |
| 2026-04-27 | 18.68 |
| 2026-04-24 | 18.49 |
| 2026-04-23 | 18.24 |
| 2026-04-22 | 19.69 |
| 2026-04-21 | 19.56 |
| 2026-04-20 | 20.14 |
| 2026-04-17 | 19.82 |
| 2026-04-16 | 19.30 |
| 2026-04-15 | 20.01 |
| 2026-04-14 | 17.57 |
| 2026-04-13 | 16.31 |
| 2026-04-10 | 15.23 |
| 2026-04-09 | 15.66 |
| 2026-04-08 | 16.85 |
| 2026-04-07 | 16.61 |
| 2026-04-06 | 16.78 |
| 2026-04-02 | 16.81 |
| 2026-04-01 | 16.68 |
| 2026-03-31 | 16.04 |
| 2026-03-30 | 15.03 |
| 2026-03-27 | 15.12 |
| 2026-03-26 | 16.15 |
| 2026-03-25 | 16.58 |
| 2026-03-24 | 17.32 |
| 2026-03-23 | 17.43 |
| 2026-03-20 | 16.66 |
| 2026-03-19 | 17.29 |
| 2026-03-18 | 17.27 |
| 2026-03-17 | 18.03 |
| 2026-03-16 | 18.05 |
| 2026-03-13 | 17.73 |
| 2026-03-12 | 17.57 |
| 2026-03-11 | 18.68 |
| 2026-03-10 | 18.05 |
| 2026-03-09 | 18.56 |
| 2026-03-06 | 18.54 |
| 2026-03-05 | 18.82 |
| 2026-03-04 | 18.19 |
| 2026-03-03 | 18.23 |
| 2026-03-02 | 18.91 |
| 2026-02-27 | 18.89 |
| 2026-02-26 | 19.65 |
| 2026-02-25 | 19.05 |
| 2026-02-24 | 20.55 |
| 2026-02-23 | 19.74 |
| 2026-02-20 | 20.11 |
| 2026-02-19 | 20.66 |
| 2026-02-18 | 19.35 |
| 2026-02-17 | 18.11 |
| 2026-02-13 | 17.90 |
| 2026-02-12 | 17.49 |
| 2026-02-11 | 18.47 |
| 2026-02-10 | 19.25 |
| 2026-02-09 | 19.68 |
| 2026-02-06 | 18.92 |
| 2026-02-05 | 18.07 |
| 2026-02-04 | 18.45 |
| 2026-02-03 | 19.28 |
| 2026-02-02 | 20.17 |
| 2026-01-30 | 20.61 |
| 2026-01-29 | 21.88 |
| 2026-01-28 | 22.24 |
| 2026-01-27 | 23.02 |
| 2026-01-26 | 23.30 |
| 2026-01-23 | 22.50 |
| 2026-01-22 | 23.55 |
| 2026-01-21 | 22.50 |
| 2026-01-20 | 23.01 |
| 2026-01-16 | 24.23 |
| 2026-01-15 | 23.74 |
| 2026-01-14 | 23.87 |
| 2026-01-13 | 23.13 |
| 2026-01-12 | 23.86 |
| 2026-01-09 | 22.83 |
| 2026-01-08 | 23.55 |
| 2026-01-07 | 24.04 |
| 2026-01-06 | 23.96 |
| 2026-01-05 | 22.29 |
| 2026-01-02 | 21.48 |
| 2025-12-31 | 20.34 |
| 2025-12-30 | 20.80 |
| 2025-12-29 | 21.18 |
| 2025-12-26 | 21.60 |
| 2025-12-24 | 22.14 |
| 2025-12-23 | 22.30 |
| 2025-12-22 | 22.71 |
| 2025-12-19 | 22.21 |
| 2025-12-18 | 21.43 |
| 2025-12-17 | 22.26 |
| 2025-12-16 | 23.46 |
| 2025-12-15 | 23.66 |
| 2025-12-12 | 24.33 |
| 2025-12-11 | 25.44 |
| 2025-12-10 | 25.86 |
| 2025-12-09 | 26.14 |
| 2025-12-08 | 26.54 |
| 2025-12-05 | 26.41 |
| 2025-12-04 | 26.30 |
| 2025-12-03 | 25.81 |
| 2025-12-02 | 25.48 |
| 2025-12-01 | 25.52 |
| 2025-11-28 | 26.85 |
| 2025-11-26 | 26.60 |
| 2025-11-25 | 26.47 |
| 2025-11-24 | 26.20 |
| 2025-11-21 | 24.21 |
| 2025-11-20 | 22.63 |
| 2025-11-19 | 23.80 |
| 2025-11-18 | 23.00 |
| 2025-11-17 | 22.87 |
| 2025-11-14 | 23.59 |
| 2025-11-13 | 23.41 |
| 2025-11-12 | 24.49 |
| 2025-11-11 | 24.65 |
| 2025-11-10 | 24.73 |
| 2025-11-07 | 24.65 |
| 2025-11-06 | 24.83 |
| 2025-11-05 | 28.34 |
| 2025-11-04 | 29.11 |
| 2025-11-03 | 49.69 |
| 2025-10-31 | 50.32 |
| 2025-10-30 | 48.32 |
| 2025-10-29 | 49.76 |
| 2025-10-28 | 48.50 |
| 2025-10-27 | 51.29 |
| 2025-10-24 | 49.98 |
| 2025-10-23 | 48.75 |
| 2025-10-22 | 47.76 |
| 2025-10-21 | 49.90 |
| 2025-10-20 | 51.78 |
| 2025-10-17 | 49.16 |
| 2025-10-16 | 50.98 |
| 2025-10-15 | 51.48 |
| 2025-10-14 | 50.33 |
| 2025-10-13 | 52.91 |
| 2025-10-10 | 53.99 |
| 2025-10-09 | 55.61 |
| 2025-10-08 | 57.83 |
| 2025-10-07 | 52.09 |
| 2025-10-06 | 52.13 |
| 2025-10-03 | 51.34 |
| 2025-10-02 | 50.02 |
| 2025-10-01 | 49.28 |
| 2025-09-30 | 45.20 |
| 2025-09-29 | 44.01 |
| 2025-09-26 | 43.96 |
| 2025-09-25 | 43.31 |
| 2025-09-24 | 44.38 |
| 2025-09-23 | 47.12 |
| 2025-09-22 | 48.09 |
| 2025-09-19 | 49.42 |
| 2025-09-18 | 48.77 |
| 2025-09-17 | 48.42 |
| 2025-09-16 | 48.75 |
| 2025-09-15 | 47.68 |
| 2025-09-12 | 48.38 |
| 2025-09-11 | 49.72 |
| 2025-09-10 | 43.78 |
| 2025-09-09 | 45.37 |
| 2025-09-08 | 44.93 |
| 2025-09-05 | 44.59 |
| 2025-09-04 | 43.75 |
| 2025-09-03 | 42.73 |
| 2025-09-02 | 43.88 |
| 2025-08-29 | 42.49 |
| 2025-08-28 | 41.26 |
| 2025-08-27 | 41.02 |
| 2025-08-26 | 42.73 |
| 2025-08-25 | 42.51 |
| 2025-08-22 | 45.10 |
| 2025-08-21 | 42.96 |
| 2025-08-20 | 41.04 |
| 2025-08-19 | 40.93 |
| 2025-08-18 | 43.94 |
| 2025-08-15 | 41.32 |
| 2025-08-14 | 40.10 |
| 2025-08-13 | 39.00 |
| 2025-08-12 | 37.16 |
| 2025-08-11 | 34.06 |
| 2025-08-08 | 34.09 |
| 2025-08-07 | 30.70 |
| 2025-08-06 | 29.03 |
| 2025-08-05 | 30.18 |
| 2025-08-04 | 30.07 |
| 2025-08-01 | 28.69 |
| 2025-07-31 | 29.58 |
| 2025-07-30 | 30.22 |
| 2025-07-29 | 30.47 |
| 2025-07-28 | 32.41 |
| 2025-07-25 | 33.71 |
| 2025-07-24 | 33.11 |
| 2025-07-23 | 33.90 |
| 2025-07-22 | 31.93 |
| 2025-07-21 | 30.32 |
| 2025-07-18 | 31.88 |
| 2025-07-17 | 31.70 |
| 2025-07-16 | 31.35 |
| 2025-07-15 | 29.21 |
| 2025-07-14 | 30.22 |
| 2025-07-11 | 29.73 |
| 2025-07-10 | 31.15 |
| 2025-07-09 | 30.53 |
| 2025-07-08 | 30.58 |
| 2025-07-07 | 30.32 |
| 2025-07-03 | 31.87 |
| 2025-07-02 | 30.93 |
| 2025-07-01 | 31.08 |
| 2025-06-30 | 33.21 |
| 2025-06-27 | 34.77 |
| 2025-06-26 | 35.72 |
| 2025-06-25 | 34.22 |
| 2025-06-24 | 35.69 |
| 2025-06-23 | 34.32 |
| 2025-06-20 | 35.71 |
| 2025-06-18 | 36.12 |
| 2025-06-17 | 36.65 |
| 2025-06-16 | 37.64 |
| 2025-06-13 | 37.26 |
| 2025-06-12 | 37.23 |
| 2025-06-11 | 37.00 |
| 2025-06-10 | 36.27 |
| 2025-06-09 | 34.99 |
| 2025-06-06 | 32.44 |
| 2025-06-05 | 30.66 |
| 2025-06-04 | 32.82 |
| 2025-06-03 | 32.39 |
| 2025-06-02 | 33.18 |
| 2025-05-30 | 28.84 |
Showing the most recent 260 of 464 data points. The chart above shows the full history.
Related Metrics
About Tempus AI, Inc.
Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Eric Lefkofsky